Goodwin advises Athagoras on the financing of the acquisition of CSO and MIGx

Goodwin LLP has advised German biotech & pharma consultant ATHAGORAS Group, a portfolio company of GREENPEAK PARTNERS, on the financing of the acquisition of CSO Pharma Consulting and MIGx AG with a team led by Munich partner Winfried M. Carli (PICTURED) and including Frankfurt associates Rebecca Stöcklein and Marius Garnatz (Private Equity/Finance).

Goodwin worked along with a Swiss team from Niederer Kraft Frey.

They parties involved

CSO provides services and professional support for pharmaceutical companies and healthcare providers in the fields of Pharmacovigilance, Medical Affairs, Quality Management & GDP as well as Development consulting. In addition, CSO offers an audited Pharmacovigilance system and processes essential for the wholesale license and as such serves as a dedicated outsourcing partner for its customers.

Founded in 2019 as a startup, MIGX has quickly established itself as a trusted technology partner in the Life Sciences sector. Specialising in solving complex data challenges and driving digital transformation, MIGX combines cutting-edge technology with deep industry expertise.

ATHAGORAS is building a group of leading service providers to create a tech-enabled European specialist service provider for the clinical and commercial development of healthcare innovations in the pharmaceutical & biotech industry within regulatory affairs, pharmacovigilance, as well as market access and real-world evidence.

GREENPEAK is a leading specialist focused on building and developing platforms that drive sustainable growth. With a hands-on approach, they collaborate closely with businesses to foster long-term value creation and success. By partnering with companies that share their vision and values, GREENPEAK creates synergistic ecosystems that fuel innovation and work toward a better future for all.

michela.cannovale@lcpublishinggroup.com

SHARE